RESEARCH DIGEST * THE DESK 08
Reach the editorial desk.
Corrections, citation questions, and editorial feedback only. No medical advice, no products, no prescriptions.
Contact the editors
This is the correspondence desk for Medicine BPC-157, where the BPC-157 record is kept and cited. Use the form for one thing: editorial mail. If you spot a citation that does not resolve, a number that looks wrong, or a study that was missed, tell us and we will check it against the source and fix it.
What this desk cannot do matters just as much. It gives no medical advice, takes no position on whether anyone should use BPC-157, and discusses no doses for individuals. It sells neither BPC-157 nor anything else, and it cannot point you to a vendor, a pharmacy, a clinic, or a telehealth provider — that is simply not what the project does.
What to expect
Messages are read as editorial mail. Anything that asks for a personal dosing protocol, a source to buy from, or clinical guidance for a specific situation will go unanswered, because answering it would misrepresent what this site is. A licensed healthcare professional is the right destination for personal health questions; this noticeboard is not.
For the regulatory picture — FDA 503A Category 2, the scheduled 2026 advisory-committee review, and how lawful compounded access works — start with BPC-157 legal status and 503A category, which is sourced entirely from the FDA's own pages. For the science, the BPC-157 research references list carries every source we cite.